Effects of grape seed extract in patients with metabolic syndrome: a randomised, double-blind, placebo-controlled trial
Sivaprakasapillai B, Edirisinghe I, Randolph J, Steinberg F, Kappagoda T
Published in Metabolism
Methodology
Four-week randomised double-blind placebo-controlled trial of grape seed extract 150 mg or 300 mg daily in adults with metabolic syndrome
Key Findings
Both doses lowered systolic and diastolic blood pressure significantly versus placebo, without change in lipids or oxidative stress markers.
Conclusions
Grape seed extract lowers blood pressure in metabolic syndrome over short-term use.
Limitations
Very small sample; four-week duration; single centre.
Supplements Studied
Both 150 mg and 300 mg daily of grape seed extract significantly lowered systolic and diastolic blood pressure in metabolic syndrome.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.